Sat Kartar

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0NB801022
  • NSEID: SATKARTAR
  • BSEID:
INR
185.10
-1.65 (-0.88%)
BSENSE

Apr 17

BSE+NSE Vol: 28800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 27.37% vs 54.16% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 38.96% vs 95.77% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 4.15% vs 8.24% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 55.66% vs 151.60% in Mar 2024

Compare Profit and Loss Results of Sat Kartar
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
162.00
67.00
95.00
141.79%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
162.00
67.00
95.00
141.79%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
1.00
-1.00
-100.00%
Raw Materials Consumed
8.00
34.00
-26.00
-76.47%
Power & Fuel Cost
2.00
0.00
2.00
0%
Employee Cost
27.00
3.00
24.00
800.00%
Operating Expenses
1.00
8.00
-7.00
-87.50%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
77.00
0.00
77.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
148.00
50.00
98.00
196.00%
Operating Profit (PBDIT) excl Other Income
14.00
17.00
-3.00
-17.65%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
14.00
20.00
-6.00
-30.00%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
14.00
19.00
-5.00
-26.32%
Depreciation
1.00
1.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
13.00
17.00
-4.00
-23.53%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
17.00
-4.00
-23.53%
Provision for Tax
3.00
4.00
-1.00
-25.00%
Profit After Tax
9.00
13.00
-4.00
-30.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
6.00
9.00
-3.00
-33.33%
Profit Available for appropriations
16.00
22.00
-6.00
-27.27%
Appropriations
16.00
22.00
-6.00
-27.27%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
7.37
11.35
-3.98
-35.07%
Profit And Loss - Net Sales
Net Sales 162.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 27.37% vs 54.16% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.23 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 38.96% vs 95.77% in Mar 2024

Profit And Loss - Interest
Interest 0.54 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.15% vs 8.24% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 9.81 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 55.66% vs 151.60% in Mar 2024